Yifan Pharmaceutical Co., Ltd. (002019.SZ)
CNY 11.34
(-2.99%)
CNY 11.34
(-2.99%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -551.07 Million CNY | -533.39% |
| 2022 | 127.15 Million CNY | -54.33% |
| 2021 | 278.39 Million CNY | -71.25% |
| 2020 | 968.39 Million CNY | 7.19% |
| 2019 | 903.46 Million CNY | 22.51% |
| 2018 | 737.43 Million CNY | -43.5% |
| 2017 | 1.3 Billion CNY | 85.18% |
| 2016 | 704.76 Million CNY | 95.46% |
| 2015 | 360.57 Million CNY | 51.56% |
| 2014 | 237.9 Million CNY | 829.0% |
| 2013 | 25.6 Million CNY | 78.85% |
| 2012 | 14.31 Million CNY | 106.22% |
| 2011 | -230.29 Million CNY | -16.57% |
| 2010 | -197.55 Million CNY | -750.49% |
| 2009 | 30.36 Million CNY | -26.35% |
| 2008 | 41.23 Million CNY | -82.83% |
| 2007 | 240.18 Million CNY | 12301.16% |
| 2006 | 1.93 Million CNY | -90.54% |
| 2005 | 20.48 Million CNY | -37.01% |
| 2004 | 32.51 Million CNY | 25.65% |
| 2003 | 25.87 Million CNY | -0.72% |
| 2002 | 26.06 Million CNY | 5.44% |
| 2001 | 24.72 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 113.15 Million CNY | 5.63% |
| 2024 Q1 | 146.09 Million CNY | 120.93% |
| 2024 Q2 | 107.12 Million CNY | -26.67% |
| 2023 FY | -551.07 Million CNY | -533.39% |
| 2023 Q2 | 43.88 Million CNY | -0.24% |
| 2023 Q1 | 43.99 Million CNY | 290.42% |
| 2023 Q3 | 38.18 Million CNY | -12.99% |
| 2023 Q4 | -697.91 Million CNY | -1927.72% |
| 2022 Q1 | 121.26 Million CNY | 1080.77% |
| 2022 FY | 127.15 Million CNY | -54.33% |
| 2022 Q2 | 25.85 Million CNY | -78.68% |
| 2022 Q4 | -23.1 Million CNY | -215.81% |
| 2022 Q3 | 19.94 Million CNY | -22.85% |
| 2021 Q4 | -12.36 Million CNY | -115.93% |
| 2021 Q2 | 80.89 Million CNY | -38.83% |
| 2021 Q3 | 77.62 Million CNY | -4.05% |
| 2021 Q1 | 132.24 Million CNY | 131.5% |
| 2021 FY | 278.39 Million CNY | -71.25% |
| 2020 FY | 968.39 Million CNY | 7.19% |
| 2020 Q4 | 57.12 Million CNY | -70.39% |
| 2020 Q3 | 192.89 Million CNY | -51.16% |
| 2020 Q2 | 394.94 Million CNY | 22.11% |
| 2020 Q1 | 323.42 Million CNY | 100.49% |
| 2019 Q1 | 147.15 Million CNY | 458.08% |
| 2019 Q2 | 338.28 Million CNY | 129.89% |
| 2019 Q3 | 256.71 Million CNY | -24.11% |
| 2019 Q4 | 161.31 Million CNY | -37.16% |
| 2019 FY | 903.46 Million CNY | 22.51% |
| 2018 Q4 | 26.36 Million CNY | -84.62% |
| 2018 Q3 | 171.42 Million CNY | -20.06% |
| 2018 FY | 737.43 Million CNY | -43.5% |
| 2018 Q1 | 325.19 Million CNY | -24.13% |
| 2018 Q2 | 214.44 Million CNY | -34.06% |
| 2017 Q4 | 428.59 Million CNY | 8.36% |
| 2017 Q3 | 395.53 Million CNY | 40.46% |
| 2017 Q2 | 281.6 Million CNY | 41.25% |
| 2017 Q1 | 199.36 Million CNY | 18.55% |
| 2017 FY | 1.3 Billion CNY | 85.18% |
| 2016 Q3 | 172.32 Million CNY | -24.31% |
| 2016 Q2 | 227.67 Million CNY | 66.69% |
| 2016 Q1 | 136.58 Million CNY | 103.7% |
| 2016 Q4 | 168.16 Million CNY | -2.41% |
| 2016 FY | 704.76 Million CNY | 95.46% |
| 2015 FY | 360.57 Million CNY | 51.56% |
| 2015 Q3 | 122.62 Million CNY | 41.42% |
| 2015 Q4 | 67.05 Million CNY | -45.32% |
| 2015 Q2 | 86.71 Million CNY | 3.0% |
| 2015 Q1 | 84.18 Million CNY | -33.45% |
| 2014 Q1 | 41.85 Million CNY | 298.51% |
| 2014 Q3 | 29.31 Million CNY | -58.4% |
| 2014 Q4 | 126.49 Million CNY | 331.45% |
| 2014 FY | 237.9 Million CNY | 829.0% |
| 2014 Q2 | 70.47 Million CNY | 68.36% |
| 2013 FY | 25.6 Million CNY | 78.85% |
| 2013 Q2 | 4.9 Million CNY | 9.56% |
| 2013 Q3 | 5.71 Million CNY | 16.46% |
| 2013 Q4 | 10.5 Million CNY | 83.76% |
| 2013 Q1 | 4.48 Million CNY | 141.02% |
| 2012 Q2 | 13.66 Million CNY | -6.08% |
| 2012 Q1 | 14.54 Million CNY | 106.86% |
| 2012 Q4 | -10.92 Million CNY | -268.18% |
| 2012 FY | 14.31 Million CNY | 106.22% |
| 2012 Q3 | -2.96 Million CNY | -121.71% |
| 2011 Q4 | -211.92 Million CNY | -8367.4% |
| 2011 FY | -230.29 Million CNY | -16.57% |
| 2011 Q1 | -7.91 Million CNY | 95.73% |
| 2011 Q2 | -7.95 Million CNY | -0.57% |
| 2011 Q3 | -2.5 Million CNY | 68.54% |
| 2010 Q2 | -10.25 Million CNY | -441.37% |
| 2010 Q4 | -185.46 Million CNY | -3736.74% |
| 2010 FY | -197.55 Million CNY | -750.49% |
| 2010 Q1 | 3 Million CNY | 281.06% |
| 2010 Q3 | -4.83 Million CNY | 52.88% |
| 2009 Q2 | 14.05 Million CNY | 175.82% |
| 2009 Q1 | 5.09 Million CNY | 118.31% |
| 2009 FY | 30.36 Million CNY | -26.35% |
| 2009 Q4 | -1.65 Million CNY | -112.89% |
| 2009 Q3 | 12.87 Million CNY | -8.42% |
| 2008 Q4 | -27.83 Million CNY | -7827.57% |
| 2008 Q2 | 26.59 Million CNY | -36.86% |
| 2008 Q3 | 360.19 Thousand CNY | -98.65% |
| 2008 Q1 | 42.11 Million CNY | -47.41% |
| 2008 FY | 41.23 Million CNY | -82.83% |
| 2007 Q2 | 69.98 Million CNY | 287.8% |
| 2007 FY | 240.18 Million CNY | 12301.16% |
| 2007 Q4 | 80.08 Million CNY | 11.11% |
| 2007 Q3 | 72.07 Million CNY | 2.99% |
| 2007 Q1 | 18.04 Million CNY | 378.35% |
| 2006 Q3 | 2.93 Million CNY | 86.77% |
| 2006 Q1 | 4.02 Million CNY | -2.18% |
| 2006 FY | 1.93 Million CNY | -90.54% |
| 2006 Q2 | 1.57 Million CNY | -60.94% |
| 2006 Q4 | -6.48 Million CNY | -320.8% |
| 2005 Q4 | 4.11 Million CNY | 241.83% |
| 2005 FY | 20.48 Million CNY | -37.01% |
| 2005 Q2 | 8.11 Million CNY | 15.24% |
| 2005 Q1 | 7.04 Million CNY | -35.93% |
| 2005 Q3 | 1.2 Million CNY | -85.17% |
| 2004 Q4 | 10.99 Million CNY | 280.71% |
| 2004 FY | 32.51 Million CNY | 25.65% |
| 2004 Q1 | 9.72 Million CNY | -1.82% |
| 2004 Q2 | 8.9 Million CNY | -8.4% |
| 2004 Q3 | 2.88 Million CNY | -67.58% |
| 2003 Q3 | 2.58 Million CNY | 0.0% |
| 2003 Q4 | 9.9 Million CNY | 283.35% |
| 2003 FY | 25.87 Million CNY | -0.72% |
| 2002 FY | 26.06 Million CNY | 5.44% |
| 2001 FY | 24.72 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 488.73 Million CNY | 212.756% |
| Zhejiang Zhenyuan Share Co., Ltd. | 81.64 Million CNY | 774.983% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | -215.14 Million CNY | -156.141% |
| Hubei Guangji Pharmaceutical Co., Ltd. | -140.24 Million CNY | -292.927% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 34.32 Million CNY | 1705.68% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.45 Billion CNY | 122.437% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -8.92 Million CNY | -6072.878% |
| Boai NKY Medical Holdings Ltd. | 493.02 Million CNY | 211.773% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 310.18 Million CNY | 277.66% |